Skip to main content
NCBI home page
Heart logoLink to Heart
. 2000 May;83(5):574–576. doi: 10.1136/heart.83.5.574

Inhibition of angiotensin converting enzyme cannot prevent increases in angiotensin II production in coronary circulation

Y Hojo 1, U Ikeda 1, T Katsuki 1, O Mizuno 1, H Fujikawa 1, K Shimada 1
PMCID: PMC1760811  PMID: 10768912

Abstract

OBJECTIVE—To determine whether inhibition of angiotensin converting enzyme (ACE) can prevent angiotensin II production in the coronary circulation induced by percutaneous transluminal coronary angioplasty (PTCA) in patients with myocardial ischaemia.
DESIGN, PATIENTS—41 patients who underwent elective PTCA and six control subjects who received diagnostic coronary angiography were studied. Patients were divided into two groups according to the chronic administration of ACE inhibitors (group A, 15 patients treated with ACE inhibitors; group B, 26 patients without ACE inhibitors). Blood samples were drawn through catheters placed in the aorta and coronary sinus before and 24 hours after PTCA.
RESULTS—Mean levels of ACE activity in the aorta were significantly lower in patients in group A than in group B. However, mean angiotensin II concentrations in the aorta were not significantly different between the two groups. Differences in basal angiotensin II concentrations between the coronary sinus and aorta, which reflected basal angiotensin II production in the coronary circulation, were not significant among group A, group B, and control subjects. The production of angiotensin II in the coronary circulation was significantly increased 24 hours after PTCA in both group A and group B to the same extent. No significant changes were observed in control subjects 24 hours after diagnostic coronary angiography.
CONCLUSIONS—This study revealed that inhibition of ACE activity by ACE inhibitors could not prevent increases in angiotensin II production in the coronary circulation induced by PTCA.


Keywords: angiotensin converting enzyme; chymase; angioplasty

Full Text

The Full Text of this article is available as a PDF (78.3 KB).

Figure 1  .

Figure 1  

Open in a new tab

Differences in angiotensin II concentrations between the coronary sinus and aorta, which reflect production of angiotensin II in the coronary circulation, increased significantly 24 hours after PTCA to the same degree in patients treated with (closed circles) and without (open circles) ACE inhibitors. No significant changes were observed in control subjects 24 hours after diagnostic coronary angiography (open squares). Data expressed as mean (SEM). *p < 0.05 versus before PTCA.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aldigier J. C., Huang H., Dalmay F., Lartigue M., Baussant T., Chassain A. P., Leroux-Robert C., Galen F. X. Angiotensin-converting enzyme inhibition does not suppress plasma angiotensin II increase during exercise in humans. J Cardiovasc Pharmacol. 1993 Feb;21(2):289–295. doi: 10.1097/00005344-199302000-00015. [DOI] [PubMed] [Google Scholar]
  2. Berk B. C., Vekshtein V., Gordon H. M., Tsuda T. Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension. 1989 Apr;13(4):305–314. doi: 10.1161/01.hyp.13.4.305. [DOI] [PubMed] [Google Scholar]
  3. Bourassa M. G. Silent myocardial ischemia after coronary angioplasty: distinguishing the shadow from the substance. J Am Coll Cardiol. 1992 Jun;19(7):1410–1411. doi: 10.1016/0735-1097(92)90595-e. [DOI] [PubMed] [Google Scholar]
  4. Capron L., Heudes D., Chajara A., Bruneval P. Effect of ramipril, an inhibitor of angiotensin converting enzyme, on the response of rat thoracic aorta to injury with a balloon catheter. J Cardiovasc Pharmacol. 1991 Aug;18(2):207–211. doi: 10.1097/00005344-199108000-00005. [DOI] [PubMed] [Google Scholar]
  5. Daemen M. J., Lombardi D. M., Bosman F. T., Schwartz S. M. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res. 1991 Feb;68(2):450–456. doi: 10.1161/01.res.68.2.450. [DOI] [PubMed] [Google Scholar]
  6. Faxon D. P. Effect of high dose angiotensin-converting enzyme inhibition on restenosis: final results of the MARCATOR Study, a multicenter, double-blind, placebo-controlled trial of cilazapril. The Multicenter American Research Trial With Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MARCATOR) Study Group. J Am Coll Cardiol. 1995 Feb;25(2):362–369. doi: 10.1016/0735-1097(94)00368-z. [DOI] [PubMed] [Google Scholar]
  7. Fischell T. A., Derby G., Tse T. M., Stadius M. L. Coronary artery vasoconstriction routinely occurs after percutaneous transluminal coronary angioplasty. A quantitative arteriographic analysis. Circulation. 1988 Dec;78(6):1323–1334. doi: 10.1161/01.cir.78.6.1323. [DOI] [PubMed] [Google Scholar]
  8. Geisterfer A. A., Peach M. J., Owens G. K. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res. 1988 Apr;62(4):749–756. doi: 10.1161/01.res.62.4.749. [DOI] [PubMed] [Google Scholar]
  9. Laporte S., Escher E. Neointima formation after vascular injury is angiotensin II mediated. Biochem Biophys Res Commun. 1992 Sep 30;187(3):1510–1516. doi: 10.1016/0006-291x(92)90473-x. [DOI] [PubMed] [Google Scholar]
  10. Libby P., Schwartz D., Brogi E., Tanaka H., Clinton S. K. A cascade model for restenosis. A special case of atherosclerosis progression. Circulation. 1992 Dec;86(6 Suppl):III47–III52. [PubMed] [Google Scholar]
  11. Mento P. F., Wilkes B. M. Plasma angiotensins and blood pressure during converting enzyme inhibition. Hypertension. 1987 Jun;9(6 Pt 2):III42–III48. doi: 10.1161/01.hyp.9.6_pt_2.iii42. [DOI] [PubMed] [Google Scholar]
  12. Miura S., Ideishi M., Sakai T., Motoyama M., Kinoshita A., Sasaguri M., Tanaka H., Shindo M., Arakawa K. Angiotensin II formation by an alternative pathway during exercise in humans. J Hypertens. 1994 Oct;12(10):1177–1181. [PubMed] [Google Scholar]
  13. Nobuyoshi M., Kimura T., Nosaka H., Mioka S., Ueno K., Yokoi H., Hamasaki N., Horiuchi H., Ohishi H. Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients. J Am Coll Cardiol. 1988 Sep;12(3):616–623. doi: 10.1016/s0735-1097(88)80046-9. [DOI] [PubMed] [Google Scholar]
  14. Okunishi H., Oka Y., Shiota N., Kawamoto T., Song K., Miyazaki M. Marked species-difference in the vascular angiotensin II-forming pathways: humans versus rodents. Jpn J Pharmacol. 1993 Jun;62(2):207–210. doi: 10.1254/jjp.62.207. [DOI] [PubMed] [Google Scholar]
  15. Salerno D. M., Granrud G., Sharkey P., Asinger R., Hodges M. A controlled trial of propafenone for treatment of frequent and repetitive ventricular premature complexes. Am J Cardiol. 1984 Jan 1;53(1):77–83. doi: 10.1016/0002-9149(84)90687-8. [DOI] [PubMed] [Google Scholar]
  16. Shiota N., Okunishi H., Fukamizu A., Sakonjo H., Kikumori M., Nishimura T., Nakagawa T., Murakami K., Miyazaki M. Activation of two angiotensin-generating systems in the balloon-injured artery. FEBS Lett. 1993 Jun 1;323(3):239–242. doi: 10.1016/0014-5793(93)81348-4. [DOI] [PubMed] [Google Scholar]
  17. Vaitkus P. T., Laskey W. K. Efficacy of adjunctive thrombolytic therapy in percutaneous transluminal coronary angioplasty. J Am Coll Cardiol. 1994 Nov 1;24(5):1415–1423. doi: 10.1016/0735-1097(94)90128-7. [DOI] [PubMed] [Google Scholar]
  18. Weber H., Webb M. L., Serafino R., Taylor D. S., Moreland S., Norman J., Molloy C. J. Endothelin-1 and angiotensin-II stimulate delayed mitogenesis in cultured rat aortic smooth muscle cells: evidence for common signaling mechanisms. Mol Endocrinol. 1994 Feb;8(2):148–158. doi: 10.1210/mend.8.2.8170471. [DOI] [PubMed] [Google Scholar]
  19. Wolny A., Clozel J. P., Rein J., Mory P., Vogt P., Turino M., Kiowski W., Fischli W. Functional and biochemical analysis of angiotensin II-forming pathways in the human heart. Circ Res. 1997 Feb;80(2):219–227. doi: 10.1161/01.res.80.2.219. [DOI] [PubMed] [Google Scholar]
  20. de Feyter P. J., van den Brand M., Laarman G. J., van Domburg R., Serruys P. W., Suryapranata H., Jaarman G. Acute coronary artery occlusion during and after percutaneous transluminal coronary angioplasty. Frequency, prediction, clinical course, management, and follow-up. Circulation. 1991 Mar;83(3):927–936. doi: 10.1161/01.cir.83.3.927. [DOI] [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES